Singapore Gastric Cancer Consortium - Bringing Discoveries to Patients

The Singapore Gastric Cancer Consortium (SGCC) is a translational research group comprising clinicians and scientists working in gastric cancer research. The group aims to solve important clinical questions to improve the care of gastric cancer patients, facilitated by close interaction between clinicians and scientists, and with synergism that enables biologic discoveries in the laboratory to be validated in the clinical setting.

Key research projects include risk susceptibility studies, biomarker discovery and validation, the genetic mapping of gastric cancer and clinical trials of novel treatment agents via novel approaches.

In July 2007, the consortium was awarded the first Translational and Clinical Research (TCR) Flagship Research Grant by the National Research Foundation (NRF) of Singapore. A five-year renewal was subsequently awarded to the consortium for 2013-2018. The consortium was further awarded the Open Fund-Large Collaborative Grant (OF-LCG) by NMRC and NRF for 2019-2024.